The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Open accessAbstract
A new infective outbreak, sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and defined coronavirus disease 2019 (COVID-19), is now spreading all around the world.[ 1 ] The clinical course of this respiratory disease is complicated in up to 15% of infected patients by onset of interstitial pneumonia, evolving toward acute respiratory distress syndrome needing mechanical ventilation or admission to the intensive care unit (ICU), and is also often accompanied by multiorgan failure.[ 2 ] Since there is now incontrovertible evidence that laboratory hemostasis provides an essential contribution to decision-making and care of the vast majority of human pathologies,[ 3 ] we aimed to explore here whether increased D-dimer values—which are a frequent occurrence in patients with COVID-19[ 4 ]—may be associated with disease severity. An electronic search was performed in Medline (PubMed interface), Scopus, and Web of Science, using the keywords “laboratory” and “COVID-19” or “coronavirus 2019” or “2019-nCoV” or “SARS-CoV-2,” between 2019 and present time (i.e., March 4, 2020), with no language restriction. The title, abstract, and full text of all documents that could be identified based on these search criteria were analyzed, and those reporting information on the difference of D-dimer values between COVID-19 patients with or without severe disease (i.e., those needing mechanical ventilation, ICU admission, or those who died) were finally included in our analysis. The reference list of each identified document was also examined for identifying additional eligible studies. A pooled analysis was finally performed, with calculation of weighted mean difference (WMD) and 95% confidence interval (CI) of D-dimer values between COVID-19 patients with or without severe disease, using MetaXL software Version 5.3 (EpiGear International Pty Ltd., Sunrise Beach, Australia). Mean and standard deviation were extrapolated from sample size, median, and interquartile range (IQR), according to Hozo et al.[ 5 ] The study was performed in accordance with the Declaration of Helsinki and with the term of local legislation. Overall, 80 documents could be initially identified based on our search criteria, 77 of which ought to be excluded after title, abstract, or full text reading; since they were review articles ( n = 6), commentaries, or other editorial material ( n = 1), they did not deal with COVID-19 disease ( n = 62), or did not expressly reported the difference of D-dimer values in COVID-19 patients with or without severe disease ( n = 8). One additional study could be identified from the reference list of selected articles and another one was published while the article was under revision so that a total number of five studies could finally be included in our analysis.[ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] Four of these five studies reported median and IQR values of D-dimer,[ 6 ] [ 7 ] [ 8 ] [ 9 ] while the remaining only showed the proportion of patients with D-dimer values above the locally defined diagnostic cut-off.[ 9 ] In the first study, Huang et al reported clinical and laboratory data of 41 patients hospitalized with laboratory-confirmed COVID-19[ 6 ] and observed that D-dimer values were nearly fivefold higher in those with severe disease (median: 2.4 mg/L; IQR: 0.6–14.4 mg/L) than in those without (median: 0.5 mg/L; IQR: 0.3–0.8 mg/L; p = 0.004). Tang et al also studied 183 patients with COVID-19[ 7 ] and found that D-dimer values were nearly 3.5-fold higher in those with severe disease (median: 2.12 mg/L; IQR: 0.77–5.27 mg/L) than in those without (median: 0.61 mg/L; IQR: 0.35–1.29 mg/L; p < 0.001). In the third study, published by Wang et al and including 138 patients hospitalized for COVID-19,[ 8 ] D-dimer values were nearly 2.5-fold higher in patients with severe disease (median: 4.14 mg/L; IQR: 1.91–13.2 mg/L) than in those without (median: 1.66 mg/L; IQR: 1.01–2.85 mg/L; p < 0.001). In the third study, Zhou et al studied 191 patients with COVID-19[ 9 ] and found that D-dimer values were nearly ninefold higher in patients who died (median: 5.2 mg/L; IQR: 1.5–21.1 mg/L) than in those who survived (median: 0.6 mg/L; IQR: 0.3–1.0 mg/L; p < 0.001). In the study of Guan et al, who extracted data on 1,099 patients with laboratory-confirmed COVID-19 infection from 552 hospitals located in 30 Chinese territories, the risk of having D-dimer values above the locally defined cut-off (i.e., ≥0.5 mg/L) was more frequent in patients with severe disease (65/109, i.e., 59.6%) than in those without (195/451, i.e., 43.2%; p = 0.002). The WMD of the four studies which reported continuous values (totaling 553 patients, 22% with severe disease)[ 6 ] [ 7 ] [ 8 ] [ 9 ] is summarized in [ Fig. 1 ], showing that D-dimer values are considerably higher in COVID-19 patients with severe disease than in those without (WMD: 2.97 mg/L; 95% CI: 2.47–3.46 mg/L). The heterogeneity across the studies was found to be relatively high (i.e.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Laboratory abnormalities in patients with COVID-2019 infection
Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0198 · Cited by 1,020
Self-citationFactors Associated with D-Dimer Levels in HIV-Infected Individuals
Borges, Á. H., O’Connor, J. L., Phillips, A. N., Baker, J. V., Vjecha, M. J., Losso, M. H., Klinker, H., Lopardo, G. D., Williams, I. G., & Lundgren, J. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090978 · Cited by 86
Zika and Chikungunya Virus and Risk for Venous Thromboembolism
Ramacciotti, E., Agati, L. B., Aguiar, V. C. R., Wolosker, N., Guerra, J. C. D. C., de Almeida, R. P., Alves, J. C., Lópes, R. D., Wakefield, T. W., Comerota, A. J., et al. (2019) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029618821184 · Cited by 52
Cited by
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Self-citationHematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,514
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis
Francone, M., Iafrate, F., Masci, G. M., Coco, S., Cilia, F., Manganaro, L., Panebianco, V., Andreoli, C., Colaiacomo, M. C., Zingaropoli, M. A., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07033-y · Cited by 806
Metadata
- Authors
- Lippi, G., & Favaloro, E. J.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2020-04-03
- Volume
- 120
- Issue
- 05
- Pages
- 876-878
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W3014713654
- Cited by
- 598
- References
- 12
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. https://app.cochat.ai/papers/10.1055/s-0040-1709650
- The paper
- Lippi, G., & Favaloro, E. J. (2020). D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0040-1709650
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.